Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity
暂无分享,去创建一个
Imir G. Metushi | R. Preissner | S. Mallal | Bjoern Peters | J. Sidney | S. Buus | J. Shabanowitz | D. Hunt | C. Moore | B. Gohlke | E. Phillips | D. Ostrov | Amanda Wriston | Priyanka Banerjee | A. English | A. Lucas | Carrie Moore
[1] S. Mallal,et al. Abacavir-Reactive Memory T Cells Are Present in Drug Naïve Individuals , 2015, PloS one.
[2] J. Shabanowitz,et al. Protein derivatization and sequential ion/ion reactions to enhance sequence coverage produced by electron transfer dissociation mass spectrometry. , 2015, International journal of mass spectrometry.
[3] J. Shabanowitz,et al. Front-end electron transfer dissociation: a new ionization source. , 2013, Analytical chemistry.
[4] Á. Santos-Briz,et al. Eczema herpeticum with herpetic folliculitis after bone marrow transplant under prophylactic acyclovir: are patients with underlying dermatologic disorders at higher risk? , 2013, Transplant infectious disease : an official journal of the Transplantation Society.
[5] Clemencia Pinilla,et al. Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture , 2013, Current protocols in immunology.
[6] S. Mallal,et al. The structural basis of HLA‐associated drug hypersensitivity syndromes , 2012, Immunological reviews.
[7] Elizabeth Phillips,et al. HLA and pharmacogenetics of drug hypersensitivity. , 2012, Pharmacogenomics.
[8] D. Margulies,et al. Abacavir induces loading of novel self-peptides into HLA-B*57: 01 an autoimmune model for HLA-associated drug hypersensitivity , 2012, AIDS.
[9] J. McCluskey,et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire , 2012, Nature.
[10] S. Mallal,et al. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire , 2012, Proceedings of the National Academy of Sciences.
[11] David Nolan,et al. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. , 2008, Immunity.
[12] Arno Formella,et al. Superimposé: a 3D structural superposition server , 2008, Nucleic Acids Res..
[13] S. Mallal,et al. HLA-B*5701 screening for hypersensitivity to abacavir. , 2008, The New England journal of medicine.
[14] Bjoern Peters,et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.
[15] Kristie L. Rose,et al. Methods for analyzing peptides and proteins on a chromatographic timescale by electron-transfer dissociation mass spectrometry , 2008, Nature Protocols.
[16] Jürgen Bajorath,et al. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. , 2007, Drug discovery today.
[17] P. Kloetzel,et al. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage,TAP transport and MHC class I binding , 2005, Cellular and Molecular Life Sciences CMLS.
[18] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[19] S. Bryant,et al. Open mass spectrometry search algorithm. , 2004, Journal of proteome research.
[20] A. Barbaud,et al. Systemic acyclovir reaction subsequent to acyclovir contact allergy: which systemic antiviral drug should then be used? , 2003, Contact dermatitis.
[21] K. Lammintausta,et al. Rapid systemic valaciclovir reaction subsequent to aciclovir contact allergy , 2001, Contact dermatitis.
[22] John Sidney,et al. Measurement of MHC/Peptide Interactions by Gel Filtration , 1999, Current protocols in immunology.
[23] Rolf Apweiler,et al. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000 , 2000, Nucleic Acids Res..
[24] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[25] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[26] R. Demars,et al. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.
[27] R. Demars,et al. Isolation of an HLA-A:,B:,C Null Human Cell Line Capable of Expressing Transferred Class I Genes , 1989 .
[28] D. Jeffries,et al. Cutaneous adverse reactions to acyclovir: case reports. , 1985, Genitourinary medicine.